Manufacturer record
Medimark Drugs & Pharmaceuticals: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
4 batches manufactured by Medimark Drugs & Pharmaceuticals (Uttarakhand) were declared Not of Standard Quality between September 2019 and January 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
4 records linked to Medimark Drugs & Pharmaceuticals in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride and Chlorpheniramine Maleate Syrup | ML25245Mfg 2025-08 · Exp 2027-07 | ContentOther | Drugs Testing Laboratory, Madurai-19State lab | Jan 2026 |
| Mefenamic Acid and Dicyclomine Hydrochloride Tablets IP (MEFSAN-SPAS TABLETS) | MT-22202Mfg 2022-07 · Exp 2024-06 | Dissolution of Dicyclomine Hydrochlorid eDissolution | RDTL ChandigarhCDSCO lab | Sep 2023 |
| WARCETIZ (Cetirizine Hydrochloride Tablets IP) | MT-21465Mfg 2021-12 · Exp 2023-11 | DescriptionDescription | RDTL GuwahatiState lab | Sep 2022 |
| Cetfast (Cetirizine Hydrochloride Tablets I.P.) | MT-17533Mfg 2018-03 · Exp 2020-02 | AssayAssay | CDL KolkataCDSCO lab | Sep 2019 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.